Porcine Parkin: Molecular cloning of PARK2 cDNA, expression analysis, and identification of a splicing variant

Biochemical and Biophysical Research Communications

Volumn 347, Issue 3, 2006, Pages 803-813

  Bjerre, Ditte ^a   Madsen, Lone Bruhn ^a   Bendixen, Christian ^a   Larsen, Knud ^a  

^a DANISH INSTITUTE OF AGRICULTURAL SCIENCES   (Denmark)

Author keywords

AR JP; Parkin; Parkinson's disease; Porcine; SNP; Splice variant

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; MESSENGER RNA; OLIGONUCLEOTIDE; PARKIN;

ANIMAL TISSUE; ARTICLE; BRAIN REGION; CEREBELLUM; CHROMOSOME 1P; CHROMOSOME MAP; COMPUTER MODEL; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; EMBRYO; EMBRYO DEVELOPMENT; EXON; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HEART; INTRON; KIDNEY; MISSENSE MUTATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; ORANG UTAN; ORTHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SWINE;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; CLONING, MOLECULAR; DNA, COMPLEMENTARY; EXONS; GENE EXPRESSION; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HYBRIDIZATION; PHYLOGENY; PHYSICAL CHROMOSOME MAPPING; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA SPLICING; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SWINE; UBIQUITIN-PROTEIN LIGASES;

PONGO PYGMAEUS; SUIDAE; SUS SCROFA;

EID: 33746214635     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.06.167     Document Type: Article

References (37)

1. Parkinson J. An Essay on the Shaking Palsy (1817), Whittingham and Rowland, London
2. de Rijk M.C., Tzourio C., Breteler M.M., F Dartigues J., Amaducci L., Lopez-Pousa S., Manubens-Bertran J.M., Alperovitch A., and Rocca W.A. Prevalence of Parkinsonism and Parkinson's disease in Europe: the Europarkinson collaborative. J. Neurol. Neurosurg. Psychiatry 62 (1997) 10-15
3. Mata I.F., Lockhart P.J., and Farrer M.J. Parkin genetics: one model for Parkinson's disease. Hum. Mol. Genet. 13 (2004) R127-R133 Review Issue 1
4. Lang A.E., and Lozano A.M. Parkinson's disease. N. Engl. J. Med. 339 (1998) 1044-1053
5. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann. N.Y Acad. Sci. (2003) 1-14
6. Forno L.S. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55 (1996) 259-272
7. Morris H.R. Genetics of Parkinson's disease. Ann. Med. 37 (2005) 86-96
8. Takahashi H., Ohama E., Suzuki S., Horikawa Y., Ishikawa A., Morita T., Tsuji S., and Ikuta F. Familial juvenile Parkinsonism: clinical and pathologic study in a family. Neurology 44 (1994) 437-441
9. Mori H., Kondo T., Yokochi M., Matsumine H., Nakagawa-Hattori Y., Miyake T., Suda K., and Mizuno Y. Pathologic and biochemical studies of juvenile Parkinsonism linked to chromosome 6q. Neurology 51 (1998) 890-892
10. Lücking C.B., Durr A., Bonifati V., Vaughan J., De Michele G., Gasser T., Harhangi B.S., Meco G., Denefle P., Wood N.W., Agid Y., and Brice A. French Parkinson's disease genetics study group; European consortium on genetic susceptibility in Parkinson's disease. Association between early-onset Parkinson's disease and mutations in the parkin gene. N. Engl. J. Med. 342 (2000) 1560-1567
11. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., and Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism. Nature 392 (1998) 605-608
12. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., and Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25 (2000) 302-305
13. Zhang Y., Gao J., Chung K.K., Huang H., Dawson V.L., and Dawson T.M. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl. Acad. Sci. USA 97 (2000) 13354-13359
14. Imai Y., Soda M., Inoue H., Hattori N., Mizuno Y., and Takahashi Y. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin. Cell 105 (2001) 891-902
15. Ciechanover A., and ubiquitin L. Parkin and synphilin-1. Nat. Med. 7 (2001) 1108-1109
16. Glickman M.H., and Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82 (2002) 373-428
17. Moore D.J., West A.B., Dawson V.L., and Dawson T.M. Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28 (2005) 57-87
18. Chung K.K., Zhang Y., Lim K.L., Tanaka Y., Huang H., Gao J., Ross C.A., Dawson V.L., and Dawson T.M. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med. 7 (2001) 1144-1150
19. Shimura H., Schlossmacher M., Hattori N., Frosch M., Trockenbacher A., Schneider R., Mizuno Y., Kosik K., and Selkoe D. Ubiquitination of a new form of synuclein by parkin from human brain: Implications for Parkinson's disease. Science 293 (2001) 263-269
20. Dong Z., Ferger B., Paterna J.C., Vogel D., Furler S., Osinde M., Feldon J., and Bueler H. Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1. Proc. Natl. Acad. Sci. USA 100 (2003) 12438-12443
21. Yang Y., Nishimura I., Imai Y., Takahashi R., and Lu B. Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron. 37 (2003) 911-924
22. Abbas N., Lücking C., Ricard S., Dürr A., Bonifati V., De Michele G., Bouley S., Vaughan J., Gasser T., Marconi R., Broussolle E., Brefel-Courbon C., Harhangi B., Oostra B., Fabrizio E., Böhme G., Pradier L., Wood N., Filla A., Meco G., Denefle P., Agid Y., and Brice A. A wide variety of mutations in the parkin gene are responsible for autosomal recessive Parkinsonism in Europe. Hum. Mol. Genet. 8 (1999) 567-574
23. Periquet M., Lucking C., Vaughan J., Bonifati V., Durr A., De Michele G., Horstink M., Farrer M., Illarioshkin S.N., Pollak P., Borg M., Brefel-Courbon C., Denefle P., Meco G., Gasser T., M Breteler M., Wood N., Agid Y., and Brice A. French Parkinson's disease genetics study group, the European consortium on genetic susceptibility in Parkinson's disease, origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from founder effects. Am. J. Hum. Genet. 68 (2001) 617-626
24. Yerle M., Echard G., Robic A., Mairal A., Dubut-Fontana C., Riquet J., Pinton P., Milan D., Lahbib-Mansais Y., and Gellin J. A somatic cell hybrid panel for pig regional gene mapping characterized by molecular cytogenetics. Cytogenet. Cell Genet. 73 (1996) 194-202
25. Tomac A.C., and Hoffer B.J. Assignment of the mouse Park2 (PARKIN), the homologue to a new human Parkinson candidate gene, to the telomeric region of mouse 17A3.2-3.3, by in situ hybridization. Cytogenet. Cell Genet. 95 (2001) 120-121
26. Kitada T., Asakawa S., Minoshima S., Mizuno Y., and Shimizu N. Molecular cloning, gene expression, and identification of a splicing variant of the mouse parkin gene. Mamm. Genome 11 (2000) 417-421
27. Lücking C.B., Abbas N., Durr A., Bonifati V., Bonnet A.M., de Broucker T., De Michele G., Wood N.W., Agid Y., and Brice A. Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile Parkinsonism. The European consortium on genetic susceptibility in Parkinson's disease and the French Parkinson's disease genetics study group. Lancet 352 (1998) 1355-1360
28. Nakaso K., Adachi Y., Yasui K., Sakuma K., and Nakashima K. Detection of compound heterozygous deletions in the parkin gene of fibroblasts in patients with autosomal recessive hereditary parkinsonism. Neurosci. Lett. 400 (2006) 44-47
29. Hedrich K., Kann M., Lanthaler A.J., Dalski A., Eskelson C., Landt O., Schwinger E., Vieregge P., Lang A.E., Breakefield X.O., Ozelius L.J., Pramstaller P.P., and Klein C. The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset Parkinsonism. Hum. Mol. Genet. 10 (2001) 1649-1656
30. Oliveira S.A., Scott W.K., Martin E.R., Nance M.A., Watts R.L., Hubble J.P., Collar W.C., Pahwa R., Stern M.B., Hiner B.C., Ondo W.G., Allen Jr. F.H., Scott B.L., Goetz C.G., Small G.W., Mastaglia F., Satanic J.M., Zhang F., Booze M.W., Winn M.P., Middleton L.T., Haines J.L., Pericak-Vance M.A., and Vance J.M. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann. Neurol. 53 (2003) 624-629
31. d'Agata V., Zhao W., and Cavallaro S. Cloning and distribution of the rat parkin mRNA. Brain Res. Mol. Brain Res. 75 (2000) 345-349
32. Pineda-Trujillo N., Carvajal-Carmona L.G., Buritica O., Moreno S., Uribe C., Pineda D., Toro M., Garcia F., Arias W., Bedoya G., Lopera F., and Ruiz-Linares A. A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile Parkinsonism in a population from North West Colombia. Neurosci. Lett. 298 (2001) 87-90
33. Shimura H., Hattori N., Kubo S., Yoshikawa M., Kitada T., Matsumine H., Asakawa S., Minoshima S., Yamamura Y., Shimizu N., and Mizuno Y. Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile Parkinsonism patients. Ann. Neurol. 45 (1999) 668-672
34. Kahle P.J., Leimer U., and Haass C. Does failure of parkin-mediated ubiquitination cause juvenile Parkinsonism?. Trends Biochem. Sci. 25 (2000) 524-527
35. Fleming S.M., Fernagut P.O., and Chesselet M.F. Genetic mouse models of Parkinsonism: strengths and limitations. NeuroRx 2 (2005) 495-503
36. Whitworth A.J., Wes P.D., and Pallanck L.J. Drosophila models pioneer a new approach to drug discovery for Parkinson's disease. DDT 11 (2006) 119-126
37. Goldberg M.S., Fleming S.M., Palacino J.J., Cepeda C., Lam H.A., Bhatnagar A., Meloni E.G., Wu N., Ackerson L.C., Klapstein G.J., Gajendiran M., Roth B.L., Chesselet M.F., Maidment N.T., Levine M.S., and Shen J. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 278 (2003) 43628-43635